Zhongyang Lv

1.9k total citations · 1 hit paper
41 papers, 1.3k citations indexed

About

Zhongyang Lv is a scholar working on Rheumatology, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhongyang Lv has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 15 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Zhongyang Lv's work include Osteoarthritis Treatment and Mechanisms (17 papers), MXene and MAX Phase Materials (5 papers) and Cancer-related molecular mechanisms research (4 papers). Zhongyang Lv is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (17 papers), MXene and MAX Phase Materials (5 papers) and Cancer-related molecular mechanisms research (4 papers). Zhongyang Lv collaborates with scholars based in China, Japan and United States. Zhongyang Lv's co-authors include Dongquan Shi, Ziying Sun, Rui Wu, Qing Jiang, Kuoyang Sun, Xingquan Xu, Hu Guo, Shiro Ikegawa, Huiming Jiang and Yizhang Wu and has published in prestigious journals such as ACS Nano, Biomaterials and Advanced Functional Materials.

In The Last Decade

Zhongyang Lv

38 papers receiving 1.2k citations

Hit Papers

TRPV1 alleviates osteoarthritis by inhibiting M1 macropha... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca2+/CaMKII/Nrf2 signaling pathway
    2021 180 citations Zhongyang Lv, Xingquan Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhongyang Lv China 20 405 357 289 223 166 41 1.3k
Heng Sun China 22 459 1.1× 534 1.5× 514 1.8× 198 0.9× 240 1.4× 42 1.6k
Xingquan Xu China 21 437 1.1× 631 1.8× 627 2.2× 169 0.8× 391 2.4× 64 2.0k
Chun‐Han Hou Taiwan 24 655 1.6× 176 0.5× 384 1.3× 107 0.5× 215 1.3× 56 1.6k
Xiangyu Deng China 21 436 1.1× 125 0.4× 850 2.9× 327 1.5× 149 0.9× 47 1.6k
Gang Zhong China 18 295 0.7× 229 0.6× 194 0.7× 81 0.4× 314 1.9× 57 1.1k
Jiajü Lü China 28 651 1.6× 141 0.4× 393 1.4× 92 0.4× 327 2.0× 96 2.0k
Baichuan Wang China 24 443 1.1× 234 0.7× 256 0.9× 52 0.2× 358 2.2× 56 1.4k
Macarena Perán Spain 25 591 1.5× 218 0.6× 379 1.3× 80 0.4× 315 1.9× 77 1.7k
Wenhui Hu China 15 407 1.0× 396 1.1× 180 0.6× 39 0.2× 145 0.9× 38 1.1k
Xuyang Zhang China 23 461 1.1× 130 0.4× 301 1.0× 63 0.3× 269 1.6× 90 1.4k

Countries citing papers authored by Zhongyang Lv

Since Specialization
Citations

This map shows the geographic impact of Zhongyang Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongyang Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongyang Lv more than expected).

Fields of papers citing papers by Zhongyang Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongyang Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongyang Lv. The network helps show where Zhongyang Lv may publish in the future.

Co-authorship network of co-authors of Zhongyang Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongyang Lv. A scholar is included among the top collaborators of Zhongyang Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongyang Lv. Zhongyang Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Dongquan, et al.. (2025). Bioactive fiber-reinforced hydrogel to tailor cell microenvironment for structural and functional regeneration of myotendinous junction. Osteoarthritis and Cartilage. 33. S339–S339. 1 indexed citations
2.
Wu, Yizhang, Xueru Song, Ziying Sun, et al.. (2025). Metal semiconductor materials in bone diseases: properties, applications, and future perspectives. Burns & Trauma. 13. tkaf055–tkaf055.
3.
Li, Jiawei, Huiming Jiang, Guihua Tan, et al.. (2025). Fibrocartilage hyalinization: A potential therapeutic strategy for articular fibrocartilage. Journal of Orthopaedic Translation. 52. 313–324. 2 indexed citations
4.
Wang, Xunhao, Siyu Xu, Nuo Xu, et al.. (2025). Growth factor independence 1 ameliorates osteoarthritis by inhibiting chondrocyte ferroptosis via inactivation of MAPK signaling pathway. Journal of Orthopaedic Translation. 54. 101–114. 2 indexed citations
5.
Sun, Ziying, Faheem Muhammad, Zheng Wang, et al.. (2024). Templated Synthesis of Hollow RuO2 Nanospheres for Alleviating Metal Wear Particle‐Induced Osteoclast Activation and Bone Loss. Small. 21(4). e2406210–e2406210. 3 indexed citations
6.
Li, Weitong, Zhongyang Lv, Peng Wang, et al.. (2024). Near Infrared Responsive Gold Nanorods Attenuate Osteoarthritis Progression by Targeting TRPV1. Advanced Science. 11(16). e2307683–e2307683. 26 indexed citations
7.
Wang, Rongliang, Zhongyang Lv, Wenshu Wu, et al.. (2024). WTAP-mediated m6A modification of FRZB triggers the inflammatory response via the Wnt signaling pathway in osteoarthritis. Experimental & Molecular Medicine. 56(1). 156–167. 23 indexed citations
8.
Lv, Zhongyang, et al.. (2024). Neutrophil-derived lactoferrin aggravates aberrant remodeling of subchondral bone in osteoarthritis. Osteoarthritis and Cartilage. 32. S438–S438. 1 indexed citations
9.
Fei, Yuxiang, Zhongyang Lv, Zizheng Liu, et al.. (2024). Promoting chondrogenesis by targeted delivery to the degenerating cartilage in early treatment of osteoarthritis. Bioactive Materials. 40. 624–633. 5 indexed citations
10.
Song, Peng, et al.. (2023). Research of STEAP3 interaction with Rab7A and RACK1 to modulate the MAPK and JAK/STAT signaling in Osteoarthritis. International Immunopharmacology. 124(Pt B). 111034–111034. 6 indexed citations
11.
Song, Xueru, Yuting Luo, Wanrong Xie, et al.. (2023). Schottky Heterojunction Realizes In Situ Vaccine‐Like Antitumor Efficacy and Microenvironment Remodeling Upon Near‐Infrared Laser Response in Cold Tumors. Advanced Functional Materials. 33(47). 18 indexed citations
12.
Sun, Ziying, Xingquan Xu, Zhongyang Lv, et al.. (2022). Intraarticular injection of SHP2 inhibitor SHP099 promotes the repair of rabbit full-thickness cartilage defect. Journal of Orthopaedic Translation. 32. 112–120. 3 indexed citations
13.
Dong, Jian, Lijun Zhang, Zhongyang Lv, et al.. (2022). NRF2 is a critical regulator and therapeutic target of metal implant particle-incurred bone damage. Biomaterials. 288. 121742–121742. 26 indexed citations
14.
Sun, Ziying, Qianqian Liu, Zhongyang Lv, et al.. (2022). Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling. Acta Pharmaceutica Sinica B. 12(7). 3073–3084. 44 indexed citations
15.
Li, Jiawei, Ziying Sun, Zhongyang Lv, et al.. (2021). Microtubule Stabilization Enhances the Chondrogenesis of Synovial Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology. 9. 748804–748804. 11 indexed citations
16.
Lv, Zhongyang & Dongquan Shi. (2021). Molecule-based osteoarthritis diagnosis comes of age. Annals of Translational Medicine. 9(14). 1112–1112. 3 indexed citations
17.
Wang, Rongliang, Jiawei Li, Xingquan Xu, et al.. (2021). Andrographolide attenuates synovial inflammation of osteoarthritis by interacting with tumor necrosis factor receptor 2 trafficking in a rat model. Journal of Orthopaedic Translation. 29. 89–99. 20 indexed citations
18.
Li, Jiawei, Rongliang Wang, Jia Xu, et al.. (2021). Methylene blue prevents osteoarthritis progression and relieves pain in rats via upregulation of Nrf2/PRDX1. Acta Pharmacologica Sinica. 43(2). 417–428. 38 indexed citations
19.
Lv, Zhongyang, Jiawei Li, Yuxiang Fei, et al.. (2021). Molecular Classification of Knee Osteoarthritis. Frontiers in Cell and Developmental Biology. 9. 725568–725568. 55 indexed citations
20.
Sun, Kuoyang, Yizhang Wu, Jia Xu, et al.. (2021). Niobium carbide (MXene) reduces UHMWPE particle-induced osteolysis. Bioactive Materials. 8. 435–448. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heng Sun Breakdown of academic impact, for papers by Xingquan Xu Breakdown of academic impact, for papers by Chun‐Han Hou Breakdown of academic impact, for papers by Xiangyu Deng Breakdown of academic impact, for papers by Gang Zhong Breakdown of academic impact, for papers by Jiajü Lü Breakdown of academic impact, for papers by Baichuan Wang Breakdown of academic impact, for papers by Macarena Perán Breakdown of academic impact, for papers by Wenhui Hu Breakdown of academic impact, for papers by Xuyang Zhang
Rankless by CCL
2026